Lymphomas | OncologyPRO

Access ESMO scientific and educational resources on Lymphomas
Recent medwireNews and resources from conferences are for ESMO Members only.

International Prognostic Index Tools for Lymphoma

Hasenclever-Index for Hodgkin's Disease

Clinical Practice Guidelines

Prognostic Tools in Mature B-cell Lymphomas and Chronic Lymphocytic Leukaemia ESMO Consensus Conference on Malignant Lymphoma: General Perspectives and Recommendations for Prognostic Tools in Mature B-cell Lymphomas and Chronic Lymphocytic Leukaemia

05 Oct 2016

Consensus Recommendations

Extranodal Diffuse Large B-Cell Lymphoma and Primary Mediastinal B-Cell Lymphoma Extranodal Diffuse Large B-Cell Lymphoma and Primary Mediastinal B-Cell Lymphoma: ESMO Clinical Practice Guidelines

23 Sep 2016

Acute Lymphoblastic Leukaemia Acute Lymphoblastic Leukaemia: ESMO Clinical Practice Guidelines

23 Sep 2016

Clinical practice guidelines

Peripheral T-Cell Lymphomas Peripheral T-Cell Lymphomas: ESMO Clinical Practice Guidelines

27 Aug 2015

Marginal Zone Lymphoma, Mantle Cell Lymphoma, Peripheral T-cell Lymphoma ESMO Consensus Guidelines: Marginal Zone Lymphoma, Mantle Cell Lymphoma, Peripheral T-cell Lymphoma

20 Feb 2013

More guidelines

Latest ESMO videos

ESMO Expert Video Report on Diffuse Large B-Cell Lymphoma

03 Jul 2019

ESMO Expert Video Report on standard approaches and new treatment options for DLBCL

17 Dec 2018

Watch all ESMO videos

Featured medwireNews

06 Mar 2020

Anticancer Agents; Complications/Toxicities of Treatment; Lymphomas

Cardiac Monitoring Need Highlighted For Non-Hodgkin’s Lymphoma Patients

05 Dec 2018

Haematological Malignancies; Immunotherapy; Lymphomas

2-Year ZUMA-1 Results Add Support For Axicabtagene Ciloleucel In Refractory Large B-Cell Lymphoma

04 Dec 2018

Haematological Malignancies; Immunotherapy; Lymphomas

High Response Rates With Tisagenlecleucel In Adult Refractory DLBCL Patients

02 Jun 2018

Anticancer Agents; Biological Therapy; Haematological Malignancies; Lymphomas; Therapy

Ibrutinib–Rituximab Improves Waldenström’s Macroglobulinemia PFS

23 May 2018

Anticancer Agents; Biological Therapy; Geriatric Oncology; Lymphomas; Therapy

Front-Line Rituximab Plus Gemcitabine–Oxaliplatin Proposed For Elderly DLBCL Patient

By Lynda Williams, Senior medwireNews Reporter

More news

E-Learning

18 Dec 2019

Haematological Malignancies; Lymphomas

ESMO E-Learning: Open Questions in the Treatment of Follicular Lymphoma

Michele Ghielmini

30 Jul 2018

Haematological Malignancies; Lymphomas

ESMO E-Learning: Mantle Cell Lymphoma

Tobias Weiglein , Martin Heinz Dreyling

30 May 2017

Haematological Malignancies; Lymphomas

ESMO E-Learning: Modern Management of DLBCL

Ruth Pettengell

04 May 2016

Haematological Malignancies; Imaging; Lymphomas

ESMO E-Learning: The Lugano Classification recommendations for Hodgkin’s and non-Hodgkin’s lymphoma: Staging, Response Assessment and Follow Up

Emanuele Zucca , Francesca Pavanello

05 Nov 2013

Haematological Malignancies; Lymphomas

ESMO E-Learning: DLBCL Clinical case - Adherence to the ESMO Clinical Practice Guidelines

Umberto Vitolo

More e-learning modules

Meeting resources

22 Nov 2020

LIVE Q&A

Presenter: Wojciech Jurczak

Session: Targeting the microenvironment in lymphomas and beyond

Resources:

Webcast

22 Nov 2020

Mantle cell lymphoma: No more chemotherapy?

Presenter: Won Seog Kim

Session: Targeting the microenvironment in lymphomas and beyond

Resources:

Slides

Webcast

22 Nov 2020

Peripheral T cell lymphoma: CHOP and beyond?

Presenter: Francesco D'Amore

Session: Targeting the microenvironment in lymphomas and beyond

Resources:

Webcast

22 Nov 2020

Follicular lymphoma

Presenter: Christian Buske

Session: Targeting the microenvironment in lymphomas and beyond

Resources:

Slides

Webcast

22 Nov 2020

Hodgkin lymphoma

Presenter: Ranjana Advani

Session: Targeting the microenvironment in lymphomas and beyond

Resources:

Slides

Webcast

More meeting resources